Skip to main content
. 2019 Nov 11;19:1081. doi: 10.1186/s12885-019-6313-x

Fig. 4.

Fig. 4

Inter-cohort comparison of subject-specific mutation prevalence. Inter-cohort comparison of subject-specific mutation prevalence (mutations/target base/subject) in (a) TP53 exons only or (b) TP53 exons, PIK3CA, and BRAF